Dr Persic is a Consultant Clinical Oncologist with special interest in breast cancer, gynaecological cancers, lymphomas and sarcomas. Dr Persic works in Derby Burton hospitals and in the private sector offering treatment with chemotherapy and radiotherapy for patients with cancer. She is endeavours to deliver best possible care to patients including offering the most up-to-date treatments.Dr Persic is passionate about the research and is the Principal Investigator for breast and gynaecological clinical trials.

Expertise and interests

Interests

Breast
Gynaecology
Haematological
Soft tissue
Breast cancer
Gynaecological oncology
Ovarian cancer
Cervix cancer
Uterus cancer
Soft tissues sarcoma
Radiotherapy for lymphoma

Accomplishments

Publications

Effect of Celecoxib vs Placebo as Adjuvant Therapy on Disease-Free Survival Among Patients With Breast Cancer: The REACT Randomized Clinical Trial (July 2021)
Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial (March 2020)
Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials (Nov 2018)
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial (Oct 2018)

Professional associations

Member of the Royal College of Physicians (RCP)
Fellow of the Royal College of Radiotherapy (RCR)

Dr Mojca Persic

MD, MRCP, FRCR, Clinical Oncologist

Overview

Centres

Specialises in

Treatments

Expertise and interests

Accomplishments

Publications

Professional associations

GenesisCare UK

Website policies

Contact us

Media & Social